Literature DB >> 21176004

Doctors' perceptions of laboratory monitoring in office practice.

Roberta E Goldman1, Christine S Soran, Geoffrey L Hayward, Steven R Simon.   

Abstract

BACKGROUND: Laboratory monitoring has been increasingly recognized as an important area for improving patient safety in ambulatory care. Little is known about doctors' attitudes towards laboratory monitoring and potential ways to improve it.
METHODS: Six focus groups and one individual interview with 20 primary care doctors and nine specialists from three Massachusetts communities.
RESULTS: Participants viewed laboratory monitoring as a critical, time-consuming task integral to their practice of medicine. Most believed they commit few laboratory monitoring errors and were surprised at the error rates reported in the literature. They listed various barriers to monitoring, including not knowing which doctor was responsible for ensuring the completion of laboratory monitoring, uncertainty regarding the necessity of monitoring, lack of alerts/reminders and patient non-adherence with recommended monitoring. The primary facilitator of monitoring was ordering laboratory tests while the patient is in the office. Primary care doctors felt more strongly than specialists that computerized alerts could improve laboratory monitoring. Participants wanted to individualize alerts for their practices and warned that alerts must not interrupt work flow or require too many clicks.
CONCLUSIONS: Doctors in community practice recognized the potential of computerized alerts to enhance their monitoring protocols for some medications. They viewed patient non-adherence as a barrier to optimal monitoring. Interventions to improve laboratory monitoring should address doctor workflow issues, in addition to patients' awareness of the importance of fulfilling recommended therapeutic monitoring to prevent adverse drug events.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21176004     DOI: 10.1111/j.1365-2753.2009.01282.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  9 in total

1.  Blame the Patient, Blame the Doctor or Blame the System? A Meta-Synthesis of Qualitative Studies of Patient Safety in Primary Care.

Authors:  Gavin Daker-White; Rebecca Hays; Jennifer McSharry; Sally Giles; Sudeh Cheraghi-Sohi; Penny Rhodes; Caroline Sanders
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

Review 2.  Biochemical monitoring of patients treated with antihypertensive therapy for adverse drug reactions: a systematic review.

Authors:  Sarah E McDowell; Robin E Ferner
Journal:  Drug Saf       Date:  2011-11-01       Impact factor: 5.606

3.  Factors associated with successful tobacco use cessation among teachers in Bihar state, India: a mixed-method study.

Authors:  E M Nagler; M Aghi; A Rathore; H Lando; M S Pednekar; P C Gupta; A M Stoddard; C Kenwood; B Penningroth; D N Sinha; G Sorensen
Journal:  Health Educ Res       Date:  2020-02-01

4.  Factors associated with ordering laboratory monitoring of high-risk medications.

Authors:  Shira H Fischer; Jennifer Tjia; George Reed; Daniel Peterson; Jerry H Gurwitz; Terry S Field
Journal:  J Gen Intern Med       Date:  2014-06-26       Impact factor: 5.128

Review 5.  Drug-Related Hospital Visits and Admissions Associated with Laboratory or Physiologic Abnormalities-A Systematic-Review.

Authors:  Kerry Wilbur; Huda Hazi; Aya El-Bedawi
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

6.  Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study.

Authors:  Jean-Pascal Fournier; Maryse Lapeyre-Mestre; Agnès Sommet; Julie Dupouy; Jean-Christophe Poutrain; Jean-Louis Montastruc
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

7.  Primary care provider perceptions of enablers and barriers to following guideline-recommended laboratory tests to confirm chronic kidney disease: a qualitative descriptive study.

Authors:  Danielle M Nash; Amit X Garg; K Scott Brimble; Maureen Markle-Reid
Journal:  BMC Fam Pract       Date:  2018-12-10       Impact factor: 2.497

8.  Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study.

Authors:  Elsy Ramia; Rony Zeenny
Journal:  Patient Prefer Adherence       Date:  2014-09-08       Impact factor: 2.711

9.  Translation of evidence into kidney transplant clinical practice: managing drug-lab interactions by a context-aware clinical decision support system.

Authors:  Zahra Niazkhani; Mahsa Fereidoni; Parviz Rashidi Khazaee; Afshin Shiva; Khadijeh Makhdoomi; Andrew Georgiou; Habibollah Pirnejad
Journal:  BMC Med Inform Decis Mak       Date:  2020-08-20       Impact factor: 2.796

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.